BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gordon LG, White NM, Elliott TM, Nones K, Beckhouse AG, Rodriguez-Acevedo AJ, Webb PM, Lee XJ, Graves N, Schofield DJ. Estimating the costs of genomic sequencing in cancer control. BMC Health Serv Res 2020;20:492. [PMID: 32493298 DOI: 10.1186/s12913-020-05318-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Vidgen ME, Williamson D, Cutler K, McCafferty C, Ward RL, McNeil K, Waddell N, Bunker D. Queensland Genomics: an adaptive approach for integrating genomics into a public healthcare system. NPJ Genom Med 2021;6:71. [PMID: 34408148 DOI: 10.1038/s41525-021-00234-4] [Reference Citation Analysis]
2 Maia N, Nabais Sá MJ, Melo-Pires M, de Brouwer APM, Jorge P. Intellectual disability genomics: current state, pitfalls and future challenges. BMC Genomics 2021;22:909. [PMID: 34930158 DOI: 10.1186/s12864-021-08227-4] [Reference Citation Analysis]
3 Gordon LG, Elliott TM, Forde B, Mitchell B, Russo PL, Paterson DL, Harris PNA. Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia. BMJ Open 2021;11:e041968. [PMID: 33526501 DOI: 10.1136/bmjopen-2020-041968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bayle A, Droin N, Besse B, Zou Z, Boursin Y, Rissel S, Solary E, Lacroix L, Rouleau E, Borget I, Bonastre J. Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting. Eur J Health Econ 2021;22:855-64. [PMID: 33765190 DOI: 10.1007/s10198-021-01293-1] [Reference Citation Analysis]
5 Akkari YMN, Baughn LB, Dubuc AM, Smith AC, Mallo M, Dal Cin P, Diez Campelo M, Gallego MS, Granada Font I, Haase DT, Schlegelberger B, Slavutsky I, Mecucci C, Levine RL, Hasserjian RP, Solé F, Levy B, Xu X. Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood 2022;139:2273-84. [PMID: 35167654 DOI: 10.1182/blood.2021014309] [Reference Citation Analysis]
6 Simons M, Van De Ven M, Coupé V, Joore M, IJzerman M, Koffijberg E, Frederix G, Uyl-De Groot C, Cuppen E, Van Harten W, Retèl V. Early technology assessment of using whole genome sequencing in personalized oncology. Expert Rev Pharmacoecon Outcomes Res 2021;21:343-51. [PMID: 33910430 DOI: 10.1080/14737167.2021.1917386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]